Management of Dyslipidaemias
Cardiovascular disease remains a leading cause of death worldwide, with low-density lipoproteins and other atherogenic lipoproteins, such as lipoprotein remnants, playing a key role in the development of atherosclerosis. Beyond LDL cholesterol, the identification of biological, environmental, and ge...
Gorde:
| Formatua: | Online |
|---|---|
| Hizkuntza: | ingelesa |
| Argitaratua: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Gaiak: | |
| Sarrera elektronikoa: | ONIX_20260416T142754_9783725856237_12 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Antzeko izenburuak: Management of Dyslipidaemias
- New Advances in Dyslipidemia
- Атеросклероз
- Advancements in Cardiovascular and Antidiabetic Drug Therapy
- New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
- КардиоСоматика
- Novel Aspects of Lipoprotein Metabolism with Focus on Systemic Inflammation